Innovation & IP
With the grant of a patent, Futura is hoping to take its Eroxon product to China, a country with a large population of ED sufferers, the firm claims.
FDA’s proposed order follows its review of OMOR DSM-Firmenich submitted showing bemotrizinol, at concentrations up to 6%, is generally recognized as safe and effective and can be added as an active ingredient to sunscreen monograph.
“In the coming years, growth will depend on whether brands can combine trust, personalization, and proof of evidence into one coherent prevention experience,” argue Simon Kucher's Clemens Oberhammer and Christian Rebholz in this exclusive interview.
The trophies have been presented at the OTC Marketing Awards 2025 - but what did the judging panel have to say about the winning and highly-commended entries?
Winners across 12 categories were announced at the OTC Marketing Awards 2025 on 20 November, with Opella crowned OTC Company of the Year.
Self-Care Week Special: HBW Insight catches up with PAGB CEO Michelle Riddalls OBE to talk about what the association is doing to promote Rx-to-OTC switch in the UK.
“It’s not good enough just to provide products anymore, we need to create a service and a holistic approach to products,” argued Bayer Consumer Health's Northern Europe general manager, Mike Knowland, speaking at a recent panel event in the UK Parliament.
Karo will take on responsibility for the marketing, distribution and sales of Moberg’s topical onychomycosis treatment, MOB-15, under the Lamisil brand in 19 European countries.
The global allergy market is “expanding again but on new terms, driven by a mix of regional strength, evolving consumer behaviors, and an increasingly diverse competitive field,” according to the latest IQVIA Consumer Health analysis.
Japan’s Ministry of Health, Labor and Welfare continues to widen access to non-prescription medicines with another Rx-to-OTC switch – Rohto Algard Epinastine Eye Drops – and a direct OTC approval of Sato Pharmaceutical's Menofeminin (black cohosh) menopause treatment.
P&G expands its WICK range with a new natural line of cough syrups; Angelini introduces a guideline-compliant Tantum Verde Duo throat spray; Zentiva adds a children’s fever product to its Ibuflam brand.
In overall terms, yes, answers IQVIA's latest Digital Health Trends report. But the market for condition-specific apps, particularly if they combine this with a high-quality user experience and strong clinical evidence, is booming.
The shortlist has been revealed for the upcoming 30th Annual OTC Marketing Awards, which takes place on Thursday 20 November in London, UK.
UK health & beauty retailer Boots has partnered with IBSA to launch a "first of its kind" orodispersible non-prescription sildenafil option.
Cemag Care may be behind the recent Rx-to-OTC switch of menstrual health treatment tranexamic acid (1000mg) in France.
Bayer’s EMEA e-commerce and commercial director, Andrew Parker, and Karo Healthcare’s global skin health category director, Sally Perry, discuss how the consumer health industry can meet today's “connected consumers” on their omnichannel shopping journey.
“Women's health isn't a niche area," noted Perrigo’s Alison Slingsby at Lynx2Market’s PharmaSynergyOTC event in Rome. Slingsby offers advice from the firm's experience in delivering some of the most innovative women's health Rx-to-OTC switches.
HBW Insight reports from the opening session of Lynx2Market’s PharmaSynergyOTC event in Rome, Italy, featuring IQVIA Consumer Health, Euromonitor International and Amazon.
Aska Pharmaceutical has recieved a green light from Japan’s Ministry of Health, Labour and Welfare for the Rx-to-OTC switch of its NorLevo (1.5mg levonorgestrel) emergency contraceptive. Controversially, OTC NorLevo will need to be taken on the spot by purchasers in the presence of a pharmacist.
Thanks to a successful reclassification by Maxwellia, UK consumers have a new option for relief from musculoskeletal pain.